|
|
|
Insider
Information: |
Hastings David C |
Relationship: |
Chief Financial Officer |
City: |
Palo Alto |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
513,590 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$1,173,656 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
513,590 |
|
|
Total
Value |
$1,173,656 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Incyte Corp |
INCY |
Chief Financial Officer |
2014-06-05 |
8,500 |
2006-04-04 |
0 |
Premium* |
|
Unilife Corp |
UNIS |
See Remarks |
2015-02-23 |
300,000 |
2015-02-23 |
0 |
Premium* |
|
Scynexis Inc |
SCYX |
|
2023-06-15 |
23,183 |
2017-06-21 |
0 |
Premium* |
|
Entasis Therapeutics Holdings Inc. |
ETTX |
Director |
2022-07-11 |
0 |
2021-04-01 |
0 |
Premium* |
|
Tekmira Pharmaceuticals Corp |
TKMR |
Chief Financial Officer |
2024-02-02 |
181,907 |
2023-02-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
31 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
UNIS |
Unilife Corp |
See Remarks |
|
2015-02-23 |
4 |
A |
$0.00 |
$0 |
D/D |
300,000 |
300,000 |
0 |
- |
|
ETTX |
Entasis Therapeutics Hold... |
Director |
|
2021-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
22,000 |
22,000 |
0 |
- |
|
ETTX |
Entasis Therapeutics Hold... |
Director |
|
2022-01-18 |
4 |
A |
$0.00 |
$0 |
D/D |
27,500 |
49,500 |
0 |
- |
|
SCYX |
Scynexis Inc |
Director |
|
2022-06-17 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
13,183 |
0 |
- |
|
TKMR |
Tekmira Pharmaceuticals C... |
Chief Financial Officer |
|
2023-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
79,000 |
79,000 |
0 |
- |
|
SCYX |
Scynexis Inc |
|
|
2023-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
23,183 |
0 |
- |
|
TKMR |
Tekmira Pharmaceuticals C... |
Chief Financial Officer |
|
2024-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
112,500 |
191,500 |
0 |
- |
|
INCY |
Incyte Corp |
Chief Financial Officer |
|
2006-04-04 |
4 |
B |
$3.60 |
$9,000 |
D/D |
2,500 |
2,500 |
2.74 |
- |
|
INCY |
Incyte Corp |
Chief Financial Officer |
|
2008-11-20 |
4 |
B |
$2.36 |
$9,440 |
D/D |
4,000 |
6,500 |
2.74 |
- |
|
SCYX |
Scynexis Inc |
Director |
|
2018-03-08 |
4 |
B |
$1.69 |
$19,999 |
D/D |
11,834 |
31,834 |
2.39 |
- |
|
INCY |
Incyte Corp |
Chief Financial Officer |
|
2010-07-01 |
4 |
B |
$10.24 |
$20,480 |
D/D |
2,000 |
8,500 |
2.74 |
- |
|
TKMR |
Tekmira Pharmaceuticals C... |
Chief Financial Officer |
|
2024-02-02 |
4 |
AS |
$2.31 |
$22,184 |
D/D |
(9,593) |
181,907 |
0 |
% |
|
SCYX |
Scynexis Inc |
Director |
|
2017-06-21 |
4 |
B |
$1.75 |
$35,000 |
D/D |
20,000 |
20,000 |
2.39 |
- |
|
ETTX |
Entasis Therapeutics Hold... |
Director |
|
2022-07-07 |
4 |
D |
$2.20 |
$48,400 |
D/D |
(22,000) |
0 |
0 |
- |
|
ETTX |
Entasis Therapeutics Hold... |
Director |
|
2022-07-11 |
4 |
D |
$2.20 |
$60,500 |
D/D |
(27,500) |
0 |
0 |
- |
|
INCY |
Incyte Corp |
Chief Financial Officer |
|
2014-02-18 |
4 |
OE |
$8.99 |
$287,689 |
D/D |
32,001 |
40,501 |
0 |
- |
|
INCY |
Incyte Corp |
Chief Financial Officer |
|
2014-02-14 |
4 |
OE |
$8.99 |
$359,600 |
D/D |
40,000 |
48,500 |
0 |
- |
|
INCY |
Incyte Corp |
Chief Financial Officer |
|
2011-06-09 |
4 |
OE |
$5.12 |
$512,000 |
D/D |
100,000 |
108,500 |
0 |
- |
|
INCY |
Incyte Corp |
Chief Financial Officer |
|
2014-06-05 |
4 |
OE |
$3.11 |
$654,020 |
D/D |
123,966 |
132,466 |
0 |
- |
|
INCY |
Incyte Corp |
Chief Financial Officer |
|
2013-02-15 |
4 |
OE |
$5.12 |
$658,800 |
D/D |
100,000 |
108,500 |
0 |
- |
|
INCY |
Incyte Corp |
Chief Financial Officer |
|
2013-09-06 |
4 |
OE |
$7.09 |
$709,000 |
D/D |
100,000 |
108,500 |
0 |
- |
|
INCY |
Incyte Corp |
Chief Financial Officer |
|
2014-06-04 |
4 |
OE |
$9.41 |
$1,030,410 |
D/D |
76,034 |
84,534 |
0 |
- |
|
INCY |
Incyte Corp |
Chief Financial Officer |
|
2011-06-09 |
4 |
S |
$17.70 |
$1,773,500 |
D/D |
(100,000) |
8,500 |
0 |
- |
|
INCY |
Incyte Corp |
Chief Financial Officer |
|
2014-02-18 |
4 |
S |
$65.64 |
$2,100,546 |
D/D |
(32,001) |
8,500 |
0 |
- |
|
INCY |
Incyte Corp |
Chief Financial Officer |
|
2013-02-15 |
4 |
S |
$22.52 |
$2,252,000 |
D/D |
(100,000) |
8,500 |
0 |
- |
|
31 Records found
|
|
Page 1 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|